For: | Seshadri RA, Glehen O. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 2016; 22(3): 1114-1130 [PMID: 26811651 DOI: 10.3748/wjg.v22.i3.1114] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v22/i3/1114.htm |
Number | Citing Articles |
1 |
思颖 朱. The Diagnosis and Treatment of Peritoneal Metastasis of Gastric Cancer. Advances in Clinical Medicine 2021; 11(01): 99 doi: 10.12677/ACM.2021.111014
|
2 |
Vaidotas Cesna, Arturas Sukovas, Aldona Jasukaitiene, Rima Naginiene, Giedrius Barauskas, Zilvinas Dambrauskas, Saulius Paskauskas, Antanas Gulbinas. Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells. World Journal of Gastroenterology 2018; 24(10): 1072-1083 doi: 10.3748/wjg.v24.i10.1072
|
3 |
Eva M. Dobrindt, Safak Gül-Klein, Miguel Enrique Alberto Vilchez, Felix Gronau, Peter Thuss-Patience, Beate Rau. Peritonealkarzinose des Magenkarzinoms. Die Chirurgie 2022; 93(12): 1133 doi: 10.1007/s00104-022-01699-4
|
4 |
Mariana Martins, Hugo Santos-Sousa, Francisco Araújo, Jorge Nogueiro, Bernardo Sousa-Pinto. Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis. Annals of Surgical Oncology 2022; 29(12): 7528 doi: 10.1245/s10434-022-12312-7
|
5 |
Sonata Trumbeckaite, Vaidotas Cesna, Aldona Jasukaitiene, Rasa Baniene, Antanas Gulbinas. Different mitochondrial response to cisplatin and hyperthermia treatment in human AGS, Caco-2 and T3M4 cancer cell lines. Journal of Bioenergetics and Biomembranes 2018; 50(5): 329 doi: 10.1007/s10863-018-9764-x
|
6 |
Paul H. Sugarbaker. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treatment Reviews 2016; 48: 42 doi: 10.1016/j.ctrv.2016.06.007
|
7 |
М.Ю. Ревтович. Results of Local Intraperitoneal Chemotherapy in Resectable Gastric Cancer of the Stage IIA–IIIC. Евразийский онкологический журнал 2020; (3): 248 doi: 10.34883/PI.2020.8.3.014
|
8 |
Fausto Rosa, Federica Galiandro, Riccardo Ricci, Dario Di Miceli, Fabio Longo, Giuseppe Quero, Antonio Pio Tortorelli, Sergio Alfieri. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center. Langenbeck's Archives of Surgery 2021; 406(6): 1847 doi: 10.1007/s00423-021-02102-2
|
9 |
Sh. Kh. Gantsev, K. Sh. Gantsev, Sh. R. Kzyrgalin, K. R. Ishmuratova. Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects. Creative surgery and oncology 2021; 11(2): 149 doi: 10.24060/2076-3093-2021-11-2-149-156
|
10 |
Maneesh Kumarsing Beeharry, Zhen-Tian Ni, Zhong Yin Yang, Ya Nan Zheng, Run Hua Feng, Wen-Tao Liu, Chao Yan, Xue Xin Yao, Chen Li, Min Yan, Zheng-Gang Zhu. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6701-2
|
11 |
Kevin E. Behrns, Jessica L. Cioffi. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 712 doi: 10.1016/B978-0-323-40232-3.00061-3
|
12 |
Lisi Zeng, Quanxing Liao, Xiaohui Zeng, Jiacai Ye, Xianzi Yang, Siyu Zhu, Hongsheng Tang, Gaojie Liu, Weiwen Cui, Shaohua Ma, Shuzhong Cui. Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer. Bioengineered 2022; 13(2): 2623 doi: 10.1080/21655979.2021.2021348
|
13 |
S.A. Aksenov, V.M. Khomyakov, A.B. Ryabov, I.V. Kolobaev, D.D. Sobolev, A.B. Utkina, K.I. Salimzyanov, A.K. Kostrygin, A.V. Chayka, A.D. Kaprin. Conversion surgery for gastric cancer with limited peritoneal carcinomatosis. P.A. Herzen Journal of Oncology 2024; 13(4): 5 doi: 10.17116/onkolog2024130415
|
14 |
Devon C. Freudenberger, Vignesh Vudatha, Andrea N. Riner, Kelly M. Herremans, Leopoldo J. Fernandez, Jose G. Trevino. A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Cancers 2022; 14(12): 2853 doi: 10.3390/cancers14122853
|
15 |
Chong-Chi Chiu, Chao-Jung Tsao, Jhi-Joung Wang, Yutaka Yonemura. Can hyperthermic intraperitoneal chemotherapy effectively control gastric cancer-associated peritoneal carcinomatosis?. World Journal of Surgical Procedures 2019; 9(1): 7-11 doi: 10.5412/wjsp.v9.i1.7
|
16 |
John H. Stewart, Dan G. Blazer, Maria Jose Godoy Calderon, Taylor M. Carter, Austin Eckhoff, Mohammad A. Al Efishat, Deemantha G. Fernando, Jason M. Foster, Andrea Hayes-Jordan, Fabian M. Johnston, Timothy B. Lautz, Edward A. Levine, Ugwuji N. Maduekwe, Christopher W. Mangieri, Omeed Moaven, Harveshp Mogal, Perry Shen, Konstantinos I. Votanopoulos. The Evolving Management of Peritoneal Surface Malignancies. Current Problems in Surgery 2021; 58(4): 100860 doi: 10.1016/j.cpsurg.2020.100860
|
17 |
June S. Peng, Jessica LaPiano, Katy Wang, Kristopher Attwood, Joseph J. Skitzki, John M. Kane, Valerie A. Francescutti. Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology 2022; 29(1): 163 doi: 10.1245/s10434-021-10556-3
|
18 |
Rokas Račkauskas, Augustinas Baušys, Jonas Jurgaitis, Marius Paškonis, Kęstutis Strupas. Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center. Journal of Clinical Medicine 2022; 11(19): 5554 doi: 10.3390/jcm11195554
|
19 |
Hisahiro Hosogi, Hisashi Shinohara, Shigeru Tsunoda, Shigeo Hisamori, Hitoshi Sumida, Koya Hida, Kazutaka Obama, Hiroshi Okabe, Yoshiharu Sakai. Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors. Langenbeck's Archives of Surgery 2017; 402(1): 33 doi: 10.1007/s00423-016-1536-7
|
20 |
Clarisse Eveno, Marc Pocard. Randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review. Pleura and Peritoneum 2016; 1(4): 169 doi: 10.1515/pp-2016-0027
|
21 |
Raquel Saiz Martínez, Clarisse Dromain, Naik Vietti Violi. Imaging of Gastric Carcinomatosis. Journal of Clinical Medicine 2021; 10(22): 5294 doi: 10.3390/jcm10225294
|
22 |
Sławomir Cieśla, Radosław Lisiecki, Agnieszka Ławnicka, Bartosz Kudliński, Paulina Ostrowska, Alberto Davì, Massimiliano Veroux, Dawid Murawa. Clinical Significance of Peritoneal Fluid Examination for Free Cancer Cells in Patients Qualified for Surgery for Gastric Cancer. Frontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.685868
|
23 |
Ana Duarte Mendes, Rodrigo Vicente, Manuel Fernandes, Michelle Silva. Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer: A Clinical Case Involving Long-Term Survival. Cureus 2023; doi: 10.7759/cureus.45302
|
24 |
Miklos Acs, Maximilian Babucke, Maximilian Jusufi, Zsolt Kaposztas, Przemyslaw Slowik, Matthias Hornung, Hans J. Schlitt, Ivan Panczel, Judit Hevesi, Jonas Herzberg, Tim Strate, Pompiliu Piso. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Innovative Surgical Sciences 2024; 9(1): 3 doi: 10.1515/iss-2023-0055
|
25 |
Hong-Wei Zhang, Jian-Jun Yang, Ji-Yang Zheng, Li Sun, Xue-Wen Yang, Guo-Cai Li. Postoperative intraperitoneal hyperthermic perfusion improve survival for advanced gastric cancer. Medicine 2019; 98(30): e16598 doi: 10.1097/MD.0000000000016598
|
26 |
Ramakrishnan Ayloor Seshadri, Akash Meinte Mehta. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 15 doi: 10.1007/978-981-10-7053-2_2
|
27 |
Allison H. Maciver, Eisar Al-Sukhni, Jesus Esquivel, Joseph J. Skitzki, John M. Kane, Valerie A. Francescutti. Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons. Annals of Surgical Oncology 2017; 24(4): 923 doi: 10.1245/s10434-016-5692-3
|
28 |
C. Paasch, G. De Santo, H.N. Gamal-Eldin, M. Hünerbein. Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study. Annals of Medicine and Surgery 2021; 70: 102824 doi: 10.1016/j.amsu.2021.102824
|
29 |
Xuhui Zhuang, Yuewen He, Wuhua Ma. Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06417-y
|
30 |
Pengfei Yu, Zeyao Ye, Gaiguo Dai, Yanqiang Zhang, Ling Huang, Yian Du, Xiangdong Cheng. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07601-x
|
31 |
Thorsten Oliver Goetze, Salah-Eddin Al-Batran, Urs Pabst, Marc Reymond, Clemens Tempfer, Wolf O. Bechstein, Ulli Bankstahl, Ines Gockel, Alfred Königsrainer, Thomas Kraus, Stefan P. Mönig, Beate Rau, Matthias Schwarzbach, Pompiliu Piso. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding – a phase II/III trial of the AIO/CAOGI/ACO. Pleura and Peritoneum 2018; 3(2) doi: 10.1515/pp-2018-0113
|
32 |
Spiliotis j. Successful Treatment of Granuloma Annulare with Tapinarof 1% Cream: A Case Report. Journal of Clinical Medical Research 2024; : 1 doi: 10.46889/JCMR.2024.5211
|
33 |
|
34 |
Jing Zhang, Yuemin Sun, Xiaofeng Bai, Peng Wang, Liang Tian, Yantao Tian, Yuxin Zhong. Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1109633
|
35 |
S. V. Osminin, F. P. Vetshev, L. M. Phakadze, G. A. Radzhabova, A. I. Salpagarova. HIPEC and PIPAC for gastric cancer: technique and comparison of efficacy. Literature review. Malignant tumours 2023; 13(4): 37 doi: 10.18027/2224-5057-2023-13-3-37-45
|
36 |
Mariana Martins, Hugo Santos-Sousa, Francisco Araújo, Jorge Nogueiro, Bernardo Sousa-Pinto. ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology 2022; 29(12): 7538 doi: 10.1245/s10434-022-12317-2
|
37 |
Ken Min Chin, Grace Hwei Ching Tan, Claramae Shulyn Chia, Johnny Chin Ann Ong, Melissa Ching Ching Teo. Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis. ANZ Journal of Surgery 2020; 90(10): 1958 doi: 10.1111/ans.15783
|
38 |
Amn Siddiqi, Fabian M. Johnston. The Perioperative and Operative Management of Esophageal and Gastric Cancer. Surgical Oncology Clinics of North America 2023; 32(1): 65 doi: 10.1016/j.soc.2022.07.006
|
39 |
Pankaj Kumar Garg, Andreas Brandl, Beate Rau. Hyperthermic Intraperitoneal Chemotherapy - Fading Perspective in the Light of Modern Systemic Chemotherapy?. Visceral Medicine 2018; 34(6): 412 doi: 10.1159/000493493
|
40 |
Firoz Rajan, Aditi Bhatt. Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. 2018; : 3 doi: 10.1007/978-981-10-7053-2_1
|
41 |
Maya Yasukawa, Koji Matsuo, Shinya Matsuzaki, Louis A. Dainty, Paul H. Sugarbaker. Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option. Journal of Obstetrics and Gynaecology Research 2021; 47(1): 44 doi: 10.1111/jog.14494
|
42 |
Hamza Khan, Fabian M. Johnston. Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease. Journal of Surgical Oncology 2022; 125(7): 1176 doi: 10.1002/jso.26894
|
43 |
Mickael Chevallay, Charles-Henri Wassmer, Pouya Iranmanesh, Minoa K Jung, Stefan P Mönig. Multimodal treatment in oligometastatic gastric cancer. World Journal of Gastrointestinal Oncology 2022; 14(2): 434-449 doi: 10.4251/wjgo.v14.i2.434
|
44 |
Elisabeth K. Petersen, Mats Bue, Christina Harlev, Andrea R. Jørgensen, Anne Schmedes, Pelle Hanberg, Lone K. Petersen, Maiken Stilling. Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure ‒ assessment in a novel porcine model. Pleura and Peritoneum 2022; 7(3): 117 doi: 10.1515/pp-2022-0110
|
45 |
Richard N. Berri, Jennifer M. Ford. Textbook of Gastrointestinal Oncology. 2019; : 395 doi: 10.1007/978-3-030-18890-0_23
|
46 |
Yuxin Zhong, Wenzhe Kang, Haitao Hu, Weikun Li, Jing Zhang, Yantao Tian. Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.995618
|
47 |
Hwee Leong Tan, Claramae Shulyn Chia, Grace Hwei Ching Tan, Su Pin Choo, David Wai‐Meng Tai, Clarinda Wei Ling Chua, Matthew Chau Hsien Ng, Khee Chee Soo, Melissa Ching Ching Teo. Metastatic gastric cancer: Does the site of metastasis make a difference?. Asia-Pacific Journal of Clinical Oncology 2019; 15(1): 10 doi: 10.1111/ajco.13025
|
48 |
Cristina Rihuete Caro, Israel Manzanedo, Fernando Pereira, Lucía Carrion-Alvarez, Ángel Serrano, Estíbalitz Pérez-Viejo. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis. European Journal of Surgical Oncology 2018; 44(11): 1805 doi: 10.1016/j.ejso.2018.06.036
|
49 |
小茜 杨. Advances in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy in Advanced or Advanced Gastric Cancer. Advances in Clinical Medicine 2022; 12(06): 5364 doi: 10.12677/ACM.2022.126777
|
50 |
Yan-Wen Liu, Ying Du, Bao-An Chen. Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials. Journal of International Medical Research 2019; 47(12): 5926 doi: 10.1177/0300060519882545
|
51 |
Martynas Luksta, Augustinas Bausys, Klaudija Bickaite, Rokas Rackauskas, Marius Paskonis, Raminta Luksaite-Lukste, Anastasija Ranceva, Rokas Stulpinas, Birute Brasiuniene, Edita Baltruskeviciene, Nadezda Lachej, Rasa Sabaliauskaite, Rimantas Bausys, Skaiste Tulyte, Kestutis Strupas. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11549-z
|
52 |
Xuhui Zhuang, Yuewen He, Wuhua Ma. Is Prophylactic Hyperthermic Intraperitoneal Chemotherapy Beneficial to the Long-Term Survival of Patients After Radical Gastric Cancer Surgery: A Systematic Review and Meta-Analysis. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3901763
|
53 |
Florian Bösch, Jens Werner. Palliative Viszeralchirurgie. 2019; : 233 doi: 10.1007/978-3-662-57362-4_18
|
54 |
Mauro Stefano, Daniele Perrina, Carlo Vallicelli, Luca Ansaloni, Paola Fugazzola, Federico Coccolini, Vanni Agnoletti, Giovanni Luca Frassineti, Alessandro Passardi, Stefano Tamberi, Massimo Framarini, Davide Tassinari, Laura Matteucci, Chiara Sturaro, Graziana Gallo, Fausto Catena. Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials. Journal of Gastrointestinal Surgery 2024; 28(7): 1185 doi: 10.1016/j.gassur.2024.04.007
|
55 |
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. V. Litvyakov, N. O. Popova, M. M. Tsyganov, L. V. Levonyan, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova. Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review). Siberian journal of oncology 2022; 20(6): 104 doi: 10.21294/1814-4861-2021-20-6-104-113
|
56 |
Małgorzata Anna Szadkowska, Jakub Pałucki, Andrzej Cieszanowski. Diagnosis and treatment of peritoneal carcinomatosis – a comprehensive overview. Polish Journal of Radiology 2023; 88: 89 doi: 10.5114/pjr.2023.125027
|
57 |
Zhong-He Ji, Kai-Wen Peng, Yang Yu, Xin-Bao Li, Yutaka Yonemura, Yang Liu, Paul H. Sugarbaker, Yan Li. Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases. International Journal of Hyperthermia 2017; 33(5): 562 doi: 10.1080/02656736.2017.1283065
|
58 |
Xinyue Wang, Jiahui Gao, Chunhua Li, Chen Xu, Xiang Li, Fanyan Meng, Qin Liu, Qin Wang, Lixia Yu, Baorui Liu, Rutian Li. In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis. Materials Today Bio 2022; 15: 100305 doi: 10.1016/j.mtbio.2022.100305
|
59 |
S. Blaj, M. Acs, M. Babucke, H. Leebmann, R. Hofheinz, E. Fokas, P. Piso. Therapie peritonealer Metastasen. Die Onkologie 2023; 29(3): 213 doi: 10.1007/s00761-022-01284-8
|
60 |
Fausto Rosa, Federica Galiandro, Riccardo Ricci, Dario Di Miceli, Fabio Longo, Giuseppe Quero, Antonio Pio Tortorelli, Sergio Alfieri. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center. Langenbeck's Archives of Surgery 2021; 406(4): 1071 doi: 10.1007/s00423-021-02137-5
|
61 |
Tian-Yu Xie, Di Wu, Shuo Li, Zhao-Yan Qiu, Qi-Ying Song, Da Guan, Li-Peng Wang, Xiong-Guang Li, Feng Duan, Xin-Xin Wang. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World Journal of Gastrointestinal Oncology 2020; 12(7): 782-790 doi: 10.4251/wjgo.v12.i7.782
|
62 |
Xi Kang, Weilin Li, Weixin Liu, Han Liang, Jingyu Deng, Chi Chun Wong, Sinan Zhao, Wei Kang, Ka Fai To, Philip Wai Yan Chiu, Guiying Wang, Jun Yu, Enders Kwok Wai Ng. LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target. Oncogene 2021; 40(19): 3422 doi: 10.1038/s41388-021-01656-1
|
63 |
Marek Mazurek, Małgorzata Szlendak, Alicja Forma, Jacek Baj, Ryszard Maciejewski, Giandomenico Roviello, Luigi Marano, Franco Roviello, Karol Polom, Robert Sitarz. Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review. International Journal of Environmental Research and Public Health 2022; 19(2): 681 doi: 10.3390/ijerph19020681
|
64 |
Mingjie Yuan, Shuyi Han, Yanfei Jia, Jiankai Feng, Duanrui Liu, Zhenguo Su, Xiangdong Liu, Zhe Fan. Statins Are Associated with Improved Survival of Patients with Gastric Cancer: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2022; 2022: 1 doi: 10.1155/2022/4938539
|
65 |
Francesco Santullo, Federica Ferracci, Carlo Abatini, Miriam Attalla El Halabieh, Claudio Lodoli, Giorgio D’Annibale, Ludovica Di Cesare, Luca D’Agostino, Silvia Pecere, Andrea Di Giorgio, Antonia Strippoli, Fabio Pacelli. Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03163-1
|
66 |
J. C. Molina, A. Al-Hinai, A. Gosseling-Tardif, P. Bouchard, J. Spicer, D. Mulder, C. L. Mueller, L. E. Ferri. Multivisceral Resection for Locally Advanced Gastric and Gastroesophageal Junction Cancers—11-Year Experience at a High-Volume North American Center. Journal of Gastrointestinal Surgery 2019; 23(1): 43 doi: 10.1007/s11605-018-3746-5
|
67 |
Beatrice J. Sun, Byrne Lee. Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases. Cancers 2022; 14(3): 570 doi: 10.3390/cancers14030570
|
68 |
Charles W. Kimbrough, Eliza Beal, Sherif Abdel-Misih, Timothy M. Pawlik, Jordan M. Cloyd. Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery. JAMA Surgery 2019; 154(8): 780 doi: 10.1001/jamasurg.2019.1698
|
69 |
Jiyun Hu, Zhenxing Wang, Xinrun Wang, Shucai Xie. Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers. PeerJ 2023; 11: e15277 doi: 10.7717/peerj.15277
|
70 |
Lei Liu, Longbo Zheng, Shanglong Liu, Maoshen Zhang, Simeng Zhang, Zinian Jiang, Chen Qin, Dongsheng Wang. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis. Journal of Gastrointestinal Surgery 2023; 27(11): 2297 doi: 10.1007/s11605-023-05823-5
|